Seasoned biotechnology executive with a special interest in novel drug development for rare diseases in both pediatric and adult indications. Expertise in regulatory strategy, international drug development guidelines, and innovative clinical trial design. Experienced in leadership through transition and growth.
Education & Training
National Institutes of Health Clinical CenterRESIDENCY
Children's National Medical Center - George Washington UniversityRESIDENCY
George Washington University School of MedicineMEDICAL_SCHOOL
Weisman, L. E., Thackray, H. M., Garcia-Prats, J. A., Nesin, M., Schneider, J. H., Fretz, J., Kokai-Kun, J. F., Mond, J. J., Kramer, W. G., Fischer, G. W.> ;Antimicrobial agents and chemotherapy. 2009 Apr 22